Global Assets Advisory’s Gilead Sciences GILD Stock Holding History

Global Assets Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Buy	+2,208	New	+$291K	0.06%	273
2023 Q1	–	Sell	-3,506	Closed	-$301K	–	139
2022 Q4	$301K	Buy	3,506 +200	+6%	+$15.8K	0.32%	87
2022 Q3	$259K	Buy	+3,306	New	+$208K	0.26%	95

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Global Assets Advisory's GILD Position: Q2 2026 in Review

Global Assets Advisory opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,208 shares worth $278K. The stake represents 0.06% of the portfolio and ranks #273 among its holdings. This is a return to the name: Global Assets Advisory previously reported a position in GILD as recently as Q4 2022.

Global Assets Advisory first reported a position in GILD in Q3 2022 and has held it in 3 quarters since. The position peaked at $301K in Q4 2022. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Global Assets Advisory held 2,208 shares of Gilead Sciences worth $278K as of Q2 2026.
Gilead Sciences was a new Global Assets Advisory position in Q2 2026.
Gilead Sciences made up 0.06% of Global Assets Advisory's portfolio in Q2 2026, its #273 holding.
Global Assets Advisory first reported a position in Gilead Sciences in Q3 2022 and has held it in 3 quarters since.
Global Assets Advisory's Gilead Sciences position peaked at $301K in Q4 2022.
759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.